Apollo, Cinven consider bids for Teva UK, Ireland, Iceland drug portfolio

Private equity heavyweights Apollo Global Management and Cinven are said to be considering bids of up to $2bn for the UK, Ireland and Iceland drug portfolio of Teva Pharmaceutical.